TY - JOUR
T1 - Effects of high-dose alacepril on the renin-angiotensin-aldosterone system and autonomic nervous system function in healthy dogs
AU - Fukayama, Toshiharu
AU - Kyojima, Hisako
AU - Koike, Mao
AU - Nakamura, Yuki
AU - Tadakuma, Asuka
AU - Doi, Takuma
AU - Goya, Seijirow
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature B.V. 2025.
PY - 2025/8
Y1 - 2025/8
N2 - This study investigated the effects of low-dose and high-dose alacepril on the renin-angiotensin-aldosterone system (RAAS) and autonomic nervous system in healthy dogs. Six Beagle dogs received low-dose (2.0 mg/kg/day) or high-dose (6.0 mg/kg/day) alacepril for 4 weeks. Blood pressure, the urinary aldosterone-to-creatinine ratio (UAld: Cre), echocardiographic variables, and heart rate variability were assessed pre- and post-treatment. High-dose alacepril reduced blood pressure and left ventricular dimensions, indicating a reduced preload and afterload. Heart rate variability analysis showed an increased percentage of successive normal-to-normal interval differences of > 50 ms, suggesting enhanced parasympathetic activity despite detecting no changes in heart rate. UAld: Cre was not significantly different. Low-dose alacepril had no significant effect on any of these variables. In conclusion, high-dose alacepril demonstrates antihypertensive effects and enhances parasympathetic activity, which may confer cardiovascular benefits. It reduces blood pressure, decreases left ventricular preload, and increases parasympathetic activity. However, both high-dose and low-dose alacepril showed incomplete RAAS suppression. These findings highlight the need for further research to clarify its therapeutic potential in heart failure and hypertension.
AB - This study investigated the effects of low-dose and high-dose alacepril on the renin-angiotensin-aldosterone system (RAAS) and autonomic nervous system in healthy dogs. Six Beagle dogs received low-dose (2.0 mg/kg/day) or high-dose (6.0 mg/kg/day) alacepril for 4 weeks. Blood pressure, the urinary aldosterone-to-creatinine ratio (UAld: Cre), echocardiographic variables, and heart rate variability were assessed pre- and post-treatment. High-dose alacepril reduced blood pressure and left ventricular dimensions, indicating a reduced preload and afterload. Heart rate variability analysis showed an increased percentage of successive normal-to-normal interval differences of > 50 ms, suggesting enhanced parasympathetic activity despite detecting no changes in heart rate. UAld: Cre was not significantly different. Low-dose alacepril had no significant effect on any of these variables. In conclusion, high-dose alacepril demonstrates antihypertensive effects and enhances parasympathetic activity, which may confer cardiovascular benefits. It reduces blood pressure, decreases left ventricular preload, and increases parasympathetic activity. However, both high-dose and low-dose alacepril showed incomplete RAAS suppression. These findings highlight the need for further research to clarify its therapeutic potential in heart failure and hypertension.
KW - Blood pressure
KW - Canine
KW - Echocardiographic variables
KW - Heart rate variability
UR - http://www.scopus.com/inward/record.url?scp=105007207631&partnerID=8YFLogxK
U2 - 10.1007/s11259-025-10782-0
DO - 10.1007/s11259-025-10782-0
M3 - Article
C2 - 40459695
AN - SCOPUS:105007207631
SN - 0165-7380
VL - 49
JO - Veterinary Research Communications
JF - Veterinary Research Communications
IS - 4
M1 - 212
ER -